Literature DB >> 15577209

Characterization of two isoforms of mouse 3(17)alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase family.

Syuhei Ishikura1, Noriyuki Usami, Satoko Nakajima, Akiko Kameyama, Hiroaki Shiraishi, Vincenzo Carbone, Ossama El-Kabbani, Akira Hara.   

Abstract

Mouse kidney contains two 3(17)alpha-hydroxysteroid dehydrogenases (HSDs) that show essentially the same properties except for their isoelectric points. However, the structural differences and physiological roles of the two enzymes remain unknown. In this study, we have isolated cDNAs for the two 3(17)alpha-HSDs from a total RNA sample of mouse kidney by reverse transcription-PCR. The identity of the cDNAs was confirmed by characterization of the recombinant enzymes that showed the same molecular weights, pI values, pH optima, substrate specificity and inhibitor sensitivity as those of the enzymes from mouse kidney. We also found that the recombinant enzymes reduce precursors of neuroactive progesterone derivatives, 5alpha-dihydrotestoserone, deoxycorticosterone, dehydroepiandrosterone, dehydroepiandrosterone sulfate and estrone at low Km values of 0.3-2 microM. The two enzymes belonged to the aldo-keto reductase (AKR) family, and their 323-amino acid sequences differed only by five amino acids. The sequences of the two isoforms are identical to those of proteins that are predicted to be encoded in a gene for AKR1C21 in the database of the mouse genome. However, the mRNAs for the two isoforms were expressed in mouse kidney and other tissues, in which their expression levels were different. The results indicate an important role of 3(17)alpha-HSD in controlling the concentrations of various steroid hormones in the mouse tissues, and suggest the existence of two genes for the two isoforms of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15577209     DOI: 10.1248/bpb.27.1939

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  6 in total

1.  Crystallization and preliminary X-ray diffraction analysis of mouse 3(17)alpha-hydroxysteroid dehydrogenase.

Authors:  Ossama El-Kabbani; Syuhei Ishikura; Armin Wagner; Clemens Schulze-Briese; Akira Hara
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-06-23

Review 2.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

3.  Structure of 3(17)alpha-hydroxysteroid dehydrogenase (AKR1C21) holoenzyme from an orthorhombic crystal form: an insight into the bifunctionality of the enzyme.

Authors:  Urmi Dhagat; Vincenzo Carbone; Roland P-T Chung; Clemens Schulze-Briese; Satoshi Endo; Akira Hara; Ossama El-Kabbani
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-09-19

4.  Tissue distribution, ontogeny, and chemical induction of aldo-keto reductases in mice.

Authors:  Matthew Pratt-Hyatt; Andrew J Lickteig; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2013-05-09       Impact factor: 3.922

5.  Progesterone synthesis in the nervous system: implications for myelination and myelin repair.

Authors:  Michael Schumacher; Rashad Hussain; Nathalie Gago; Jean-Paul Oudinet; Claudia Mattern; Abdel M Ghoumari
Journal:  Front Neurosci       Date:  2012-02-08       Impact factor: 4.677

6.  Structure-function characterization of an aldo-keto reductase involved in detoxification of the mycotoxin, deoxynivalenol.

Authors:  Nadine Abraham; Kurt L Schroeter; Yan Zhu; Jonathan Chan; Natasha Evans; Matthew S Kimber; Jason Carere; Ting Zhou; Stephen Y K Seah
Journal:  Sci Rep       Date:  2022-08-30       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.